What is Retatrutide?
Retatrutide is a multi-receptor agonist researched for GLP-1, GIP, and glucagon signaling in metabolic models.
Retatrutide dosage snapshot
- Route
- subQ
- Dose range
- 1-12 mg titrated
- Frequency
- 1x weekly
- Duration
- 48+ weeks in trials
Based on reported research sources; not a dosing instruction.
Potential benefits
- Weight loss
- Appetite control
- Metabolic health
- Body composition
- Blood-sugar control
Safety profile
Moderate risk- Common: Nausea, vomiting, and diarrhea, especially during dose escalation.
- Less common: Injection-site reactions, fatigue, decreased appetite, or constipation.
- Caution: Long-term safety remains under study; retatrutide is not yet an approved medicine.
- Stop use: Severe abdominal pain, persistent vomiting, signs of allergic reaction, or severe dehydration symptoms.
Storage and handling
Store according to product-label instructions and batch handling notes. Lyophilized research peptides are commonly kept dry, protected from light, and handled with clean laboratory technique.